Down Syndrome

Microbleeds in individuals with Down Syndrome: Implications for Alzheimer’s disease treatment

by

Anti-amyloid drugs have emerged as a promising treatment for Alzheimer’s disease. However, these treatments can potentially cause cerebral microbleeds – small brain bleeds that may occur when amyloid is cleared from blood vessels. Understanding the natural history of these microbleeds is crucial for safe patient treatment and monitoring. This study, published in Neurology, provides key … Read more

Awarded with the SEN 2023 Prizes

by

Dr. Juan Fortea Ormaechea, director of the Memory Unit at Sant Pau Hospital, has been awarded the Scientific Modality Prize in the Alzheimer’s category during the Institutional Act of the Spanish Society of Neurology (SEN), held on June 6, 2024, at the Fonseca College of Santiago de Compostela. This prestigious recognition underscores Dr. Fortea’s world-class … Read more

Clinical trials

by

Join the fight against Alzheimer’s disease People with Down syndrome often develop Alzheimer’s disease as they age. This disease leads to the accumulation of a protein called amyloid in the brain, as well as a progressive loss of cognitive abilities, such as memory loss, language, or orientation, among others. The ABATE study is evaluating a … Read more